Product Code: FB9355
Global AI in nutraceuticals market size reached US$ 1.32 billion in 2024 and is expected to reach US$ 2.48 billion by 2032, growing with a CAGR of 8.19% during the forecast period 2025-2032.
Artificial Intelligence (AI) is revolutionizing the nutraceuticals industry by enhancing various aspects such as product development, supply chain management, and personalized nutrition solutions. By analyzing vast datasets, AI enables the identification of new bioactive compounds and the optimization of formulations to meet specific health needs. This technological integration facilitates more efficient production processes and accelerates time-to-market for innovative products.
In addition, AI-driven personalized nutrition is gaining traction, allowing consumers to receive tailored dietary recommendations based on genetic, lifestyle, and health data. Also, in February 2025, Nutrify Today, a trailblazer in AI-driven nutraceutical advancements, launched Dealsphere, a game-changing platform designed to revolutionize how businesses discover, license, and commercialize science-backed nutrition products.
Market Dynamics
Personalized Nutrition Advancements
The rise of personalized nutrition is a significant driver for AI adoption in the nutraceuticals market. AI algorithms analyze individual health data to provide customized dietary recommendations, aligning with the growing consumer desire for personalized health solutions. This trend not only improves consumer satisfaction but also opens new avenues for product development, as companies can create targeted nutraceuticals that cater to specific nutritional needs.
Data Privacy and Regulatory Challenges
Despite its potential, the integration of AI in nutraceuticals faces challenges related to data privacy and regulatory compliance. Collecting and analyzing personal health data necessitates stringent data protection measures to maintain consumer trust and comply with regulations such as the General Data Protection Regulation (GDPR). Navigating these complexities requires significant investment in secure data management systems and continuous monitoring of evolving legal frameworks.
In 2023, the Nutrition Business Journal reported that sales of personalized supplements would reach $1.15 billion by the end of 2024, highlighting the growing importance of data privacy and regulatory compliance in the nutraceutical industry.
Segment Analysis
The global AI in nutraceutical market is segmented based on product type, application, technology, deployment mode and region.
AI-Powered Dietary Supplements are Gaining Traction in the Market
Dietary supplements, such as vitamins, minerals, and herbal extracts, remain a dominant segment due to their convenience and targeted health benefits. Functional foods, which are fortified with additional nutrients, are gaining popularity as consumers seek to enhance their daily diets without altering eating habits significantly. Functional beverages, including energy drinks and fortified juices, are experiencing rapid growth driven by the demand for convenient health solutions. These products cater to busy lifestyles, offering quick and accessible nutritional benefits, thus expanding their consumer base.
In October 2024, an antiaging supplement was launched featuring a plant-based peptide ingredient from Irish firm Nuritas that is the fruit of a development effort that used an artificial intelligence (AI) platform. The new supplement, branded as Performance Peptides, has been launched by Florida family-owned firm Designs for Health.
Geographical Penetration
Rapid Technological Advancements in North America.
North America continues to lead the global nutraceuticals market, driven by a surge in consumer focus on wellness. In 2024, the United States captured over 20.4% of the global market value, fueled by rising demand for fermented foods like yogurt among health-conscious consumers. The region's aging population and high prevalence of chronic diseases have further spurred interest in preventive healthcare products, solidifying North America's position as a dominant market player.
Technology Analysis
Technological advancements are at the forefront of the nutraceuticals industry's evolution. Beyond AI, technologies such as blockchain are being implemented to enhance transparency and traceability in the supply chain. This integration ensures product authenticity and builds consumer trust. Additionally, advancements in biotechnology are enabling the development of novel ingredients with enhanced bioavailability, thereby increasing the efficacy of nutraceutical products.
Competitive Landscape
The major global players in the market include Nestle Health Science, Danone S.A., BASF SE, Herbalife Nutrition Ltd., Ingredion Incorporated, Archer Daniels Midland Company (ADM), Yakult Honsha Co., Ltd., Otsuka Holdings Co., Ltd., Koninklijke DSM N.V., and NOW Health Group, Inc.
Why Choose DataM?
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
Table of Contents
1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
- 3.1. Snippet by Product Type
- 3.2. Snippet by Application
- 3.3. Snippet by Technology
- 3.4. Snippet by Deployment Mode
- 3.5. Snippet by Region
4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Personalized Nutrition Advancements
- 4.1.2. Restraints
- 4.1.2.1. Data Privacy and Regulatory Challenges
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Value Chain Analysis
- 5.4. Pricing Analysis
- 5.5. Regulatory and Compliance Analysis
- 5.6. AI & Automation Impact Analysis
- 5.7. R&D and Innovation Analysis
- 5.8. Technology Analysis
- 5.9. DMI Opinion
6. By Product Type
- 6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
- 6.2. Dietary Supplements*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.3. Functional Foods
- 6.4. Functional Beverages
- 6.5. Herbal & Botanical Extracts
- 6.6. Others
7. By Application
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
- 7.2. Product Formulation*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Personalized Nutrition
- 7.4. Quality Control & Safety Assurance
- 7.5. Supply Chain Optimization
- 7.6. Others
8. By Technology
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 8.1.2. Market Attractiveness Index, By Technology
- 8.2. AI and Machine Learning*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Natural Language Processing (NLP)
- 8.4. Computer Vision
- 8.5. Predictive Analytics
- 8.6. Deep Learning
- 8.7. Others
9. By Deployment Mode
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
- 9.1.2. Market Attractiveness Index, By Deployment Mode
- 9.2. Cloud-Based AI Solutions*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. On-Premise AI Solutions
10. By Region
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
- 10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.2.7.1. U.S.
- 10.2.7.2. Canada
- 10.2.7.3. Mexico
- 10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.3.7.1. Germany
- 10.3.7.2. UK
- 10.3.7.3. France
- 10.3.7.4. Italy
- 10.3.7.5. Russia
- 10.3.7.6. Rest of Europe
- 10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.4.7.1. Brazil
- 10.4.7.2. Argentina
- 10.4.7.3. Rest of South America
- 10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.5.7.1. China
- 10.5.7.2. India
- 10.5.7.3. Japan
- 10.5.7.4. Australia
- 10.5.7.5. Rest of Asia-Pacific
- 10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
11. Competitive Landscape
- 11.1. Competitive Scenario
- 11.2. Market Positioning/Share Analysis
- 11.3. Mergers and Acquisitions Analysis
12. Company Profiles
- 12.1. BASF SE*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
- 12.2. Nestle Health Science
- 12.3. Danone S.A.
- 12.4. Herbalife Nutrition Ltd.
- 12.5. Ingredion Incorporated
- 12.6. Archer Daniels Midland Company (ADM)
- 12.7. Yakult Honsha Co., Ltd.
- 12.8. Otsuka Holdings Co., Ltd.
- 12.9. Koninklijke DSM N.V. (Royal DSM)
- 12.10. NOW Health Group, Inc.
LIST NOT EXHAUSTIVE
13. Appendix
- 13.1. About Us and Services
- 13.2. Contact Us